Li M - Search Results

1

First orally bioavailable prodrug of proteolysis targeting chimera (PROTAC) degrades cyclin-dependent kinases 2/4/6 in vivo.

Wei M, Zhao R, Cao Y, Wei Y, Li M, Dong Z, Liu Y, Ruan H, Li Y, Cao S, Tang Z, Zhou Y, Song W, Wang Y, Wang J, Yang G, Yang C. Wei M, et al. Among authors: li y, li m. Eur J Med Chem. 2021 Jan 1;209:112903. doi: 10.1016/j.ejmech.2020.112903. Epub 2020 Oct 9. Eur J Med Chem. 2021. PMID: 33256948

2

Design, synthesis and biological evaluation of novel glycosylated diphyllin derivatives as topoisomerase II inhibitors.

Shi DK, Zhang W, Ding N, Li M, Li YX. Shi DK, et al. Among authors: li yx, li m. Eur J Med Chem. 2012 Jan;47(1):424-31. doi: 10.1016/j.ejmech.2011.11.011. Epub 2011 Nov 13. Eur J Med Chem. 2012. PMID: 22119124

3

Discovery of Novel c-Mesenchymal-Epithelia transition factor and histone deacetylase dual inhibitors.

Hu H, Chen F, Dong Y, Li M, Xu S, Qin M, Gong P. Hu H, et al. Among authors: li m. Eur J Med Chem. 2020 Oct 15;204:112651. doi: 10.1016/j.ejmech.2020.112651. Epub 2020 Jul 22. Eur J Med Chem. 2020. PMID: 32738414

4

Synthesis of a series of novel dihydroartemisinin derivatives containing a substituted chalcone with greater cytotoxic effects in leukemia cells.

Yang X, Wang W, Tan J, Song D, Li M, Liu D, Jing Y, Zhao L. Yang X, et al. Among authors: li m. Bioorg Med Chem Lett. 2009 Aug 1;19(15):4385-8. doi: 10.1016/j.bmcl.2009.05.076. Epub 2009 May 27. Bioorg Med Chem Lett. 2009. PMID: 19501507

5

A series of alpha-heterocyclic carboxaldehyde thiosemicarbazones inhibit topoisomerase IIalpha catalytic activity.

Huang H, Chen Q, Ku X, Meng L, Lin L, Wang X, Zhu C, Wang Y, Chen Z, Li M, Jiang H, Chen K, Ding J, Liu H. Huang H, et al. Among authors: li m. J Med Chem. 2010 Apr 22;53(8):3048-64. doi: 10.1021/jm9014394. J Med Chem. 2010. PMID: 20353152

6

Design, synthesis and biological activity of flavonoid derivatives as selective agonists for neuromedin U 2 receptor.

Ma ML, Li M, Gou JJ, Ruan TY, Jin HS, Zhang LH, Wu LC, Li XY, Hu YH, Wen K, Zhao Z. Ma ML, et al. Among authors: li xy, li m. Bioorg Med Chem. 2014 Nov 1;22(21):6117-23. doi: 10.1016/j.bmc.2014.08.038. Epub 2014 Sep 8. Bioorg Med Chem. 2014. PMID: 25262941

7

Effects of probiotics on chemotherapy in patients with lung cancer.

Tian Y, Li M, Song W, Jiang R, Li YQ. Tian Y, et al. Among authors: li m, li yq. Oncol Lett. 2019 Mar;17(3):2836-2848. doi: 10.3892/ol.2019.9906. Epub 2019 Jan 8. Oncol Lett. 2019. PMID: 30854059 Free PMC article.

8

Design, synthesis and biological evaluation of novel thieno[3,2-d]pyrimidine and quinazoline derivatives as potent antitumor agents.

Hu H, Dong Y, Li M, Wang R, Zhang X, Gong P, Zhao Y. Hu H, et al. Among authors: li m. Bioorg Chem. 2019 Sep;90:103086. doi: 10.1016/j.bioorg.2019.103086. Epub 2019 Jun 26. Bioorg Chem. 2019. PMID: 31280016

9

Cannabidiol-dihydroartemisinin conjugates for ameliorating neuroinflammation with reduced cytotoxicity.

Wang F, Li M, Lin C, Jin S, Li H, Lu Y, Wang H, Wang H, Wang X. Wang F, et al. Among authors: li h, li m. Bioorg Med Chem. 2021 Jun 1;39:116131. doi: 10.1016/j.bmc.2021.116131. Epub 2021 Apr 2. Bioorg Med Chem. 2021. PMID: 33852975

10

Synthesis and cytotoxicities of dioscin derivatives with decorated chacotriosyl residues.

Zhu S, Zhang Y, Li M, Yu J, Zhang L, Li Y, Yu B. Zhu S, et al. Among authors: li y, li m. Bioorg Med Chem Lett. 2006 Nov 1;16(21):5629-32. doi: 10.1016/j.bmcl.2006.08.019. Epub 2006 Aug 14. Bioorg Med Chem Lett. 2006. PMID: 16905317

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,700 results

Search Page

Filters